GSK buys out Novartis in $13bn consumer healthcare deal
27-03-2018
designer491 / iStockphoto.com
Procter & Gamble (P&G) has announced plans to buy the consumer health business of Merck KGaA for €3.4 billion ($4.2 billion).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Mergers and acquisitions, Procter & Gamble, consumer health, M&A, Merck KGaA,
